We serve Chemical Name:5-chloro-7-pyridin-4-ylquinoline CAS:1211595-82-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-chloro-7-pyridin-4-ylquinoline
CAS.NO:1211595-82-2
Synonyms:5-chloro-7-(pyridin-4-yl)quinoline
Molecular Formula:C14H9ClN2
Molecular Weight:240.68800
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:25.78000
Exact Mass:240.04500
LogP:3.95020
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-chloro-7-(pyridin-4-yl)quinoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-chloro-7-(pyridin-4-yl)quinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-chloro-7-(pyridin-4-yl)quinoline Use and application,5-chloro-7-(pyridin-4-yl)quinoline technical grade,usp/ep/jp grade.
Related News: An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant. 5-chloro-7-pyridin-4-ylquinoline manufacturer Though Innova previously applied for a regulatory green light, the test has not been authorized or approved by the FDA for use in the U.S.—however, during inspections of the company’s California facilities in March and April, FDA investigators said they found the test was already being sold and distributed. 5-chloro-7-pyridin-4-ylquinoline supplier The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth. 5-chloro-7-pyridin-4-ylquinoline vendor Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity. 5-chloro-7-pyridin-4-ylquinoline factory The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.